George-August University Göttingen, Germany
Michael Oellerich is a chemical pathologist and currently a Distinguished Research Professor at the Department of Clinical Pharmacology, University Medical Center (UMG) of the George-August-University Göttingen, Germany. From 2012 to 2017, he had an appointment as a Lower Saxony Distinguished Professor and he was chairman of the Department of Clinical Chemistry/Central Laboratory at UMG from 1991 to 2012. He received Fellowships of the Royal College of Pathologists (FRCPath) in 2006, of the Faculty of Pathology of the Royal College of Physicians of Ireland [FFPath (RCPI)] in 2006, of the AACC Academy (FAACC) of the American Association for Clinical Chemistry in 2012, and of the Academy of Medicine of Malaysia (FAMM) in 2014. Since 2013, he is a member of the Transplantation Advisory Board of Chronix Biomedical Inc., San Jose, CA, USA. From 1996 to 1998, he served as Dean of the Faculty of Medicine and as the deputy of the chief executive for research and teaching on the executive board for the Medical Center and Faculty of Medicine (1999-2004). He was president of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) from 1997 to 1999, of the German Association for Laboratory Medicine (2001-2002), and of the German United Association for Clinical Chemistry and Laboratory Medicine (2003-2005). Subsequently, he was secretary-treasurer of the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM) (2005-2007), president (2009-2011), immediate past-president (2011-2013), and director Europe (2013-2017). Since 2016, he is Executive Secretary of the International Society of Enzymology and since 2017, Chief Research Officer of the Liquid Biopsy Center GmbH (LBC), Göttingen, Germany. He was Editor-in-Chief of the journal Therapeutic Drug Monitoring (2003-2018) and currently is Associate Editor of this journal. Guest Editorships include special issues of Clin Chim Acta (2012) and JALM (2020). He is on the Editorial Boards of Clinical Biochemistry (2015-) as well as of J Mol Clin Pathol, Folia Med, Turk J Pediatr Biochem, and Indian J Clin Biochem. He is member of the Advisory Boards of Ital J Lab Med and Braz J Pathol Lab Med. His current research interests are in the field of therapeutic drug monitoring, with particular focus on endogenous biomarkers to achieve personalized immunosuppression in transplantation (e.g. graft-derived circulating cell-free DNA), as well as ctDNA as a „liquid biopsy“ in cancer. Further topics included proteomics, and analytical techniques (e.g. LC-MS/MS). He has authored more than 470 publications (articles contributed to scientific journals, book chapters, books edited). He received the following awards: Ludolf-Krehl prize of the S.W. German Society for Internal Medicine in 1971, the IATDMCT Award, Cairns (Australia) 1999, the IATDMCT Charles Pippenger Award for Outstanding Contributions to Therapeutic Drug Monitoring, Washington (USA) 2001, the 2002 Canadian Society of Clinical Chemists Travelling Lectureship Award, the Professor-Landbeck-Award of the Society for Thrombosis and Hemostasis Research, Hamburg (Germany) 2004, the Perth PathCentre Visiting Lectureship, Western Australia 2004, the WASPaLM Medal of Honor, Las Vegas (USA) 2011, the WASPaLM Gold Headed Cane, Quebec City (Canada) 2013, and the Sign of Honor, Professor Jordan Todoroff, of the BSCL, Sofia (Bulgaria) 2019.